Yvan Butera

Yvan Butera

Auto-generated profile, based on publicly available information

Yvan Butera

Ministry of Health, Street KK739ST Kanombe, Kicukiro District, Kigali City, P.O.Box: 3377, Kigali, Rwanda

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2020 in Nature
Verified
Journal Article
Closed access
PDF file
LMLeon Mutesa
Leon Mutesa
PNPacifique Ndishimye
Pacifique Ndishimye
YBYvan Butera
Yvan Butera
Jacob SouopguiJacob Souopgui
Jacob Souopgui
AUAnnette Uwineza
Annette Uwineza
WNWilfred Ndifon
Wilfred Ndifon

7 October 2022 in Science
Verified
Journal Article
Closed access
HTHouriiyah Tegally
Houriiyah Tegally
JSJames Emmanuel San
James Emmanuel San
MCMatthew Cotten
Matthew Cotten
MMMonika Moir
Monika Moir
BTBryan Tegomoh
Bryan Tegomoh
EWEduan Wilkinson
Eduan Wilkinson
Investment in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing in Africa over the past year has led to a major increase in the number of sequences that have been generated and used to track the pandemic on the continent, a number that now exceeds 100,000 genomes. Our results show an increase in the number of African countries that are able to sequence domestically and highlight that local sequencing enables faster turnaround times and more-regular routine surveillance. Despite limitations of low testing proportions, findings from this genomic surveillance study underscore the heterogeneous nature of the pandemic and illuminate the distinct dispersal dynamics of variants of concern—particularly Alpha, Beta, Delta, and Omicron—on the continent. Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve while the continent faces many emerging and reemerging infectious disease threats. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century.

16 December 2024 in Nature Medicine
Verified
Journal Article
Open access
PDF file
YBYvan Butera
Yvan Butera
LMLeon Mutesa
Leon Mutesa
EPEdyth Parker
Edyth Parker
RMRaissa Muvunyi
Raissa Muvunyi
EUEsperance Umumararungu
Esperance Umumararungu
Claude Mambo MuvunyiClaude Mambo Muvunyi
Claude Mambo Muvunyi
The ongoing outbreak of Marburg virus disease in Rwanda marks the third largest historically, although it has shown the lowest fatality rate. Genomic analysis of samples from 18 cases identified a lineage with limited internal diversity, closely related to a 2014 Ugandan case. Our findings suggest that the Rwandan lineage diverged decades ago from a common ancestor shared with diversity sampled from bats in Uganda. Our genomic data reveal limited genetic variation, consistent with a single zoonotic transmission event and limited human-to-human transmission. Investigations including contact tracing, clinical assessments, sequencing and serology, linked the index case to a mining cave inhabited by Rousettus aegyptiacus. Serology tests identified three individuals seropositive for immunoglobulin G and immunoglobulin M, further supporting the zoonotic origin of the outbreak through human–animal interactions.

7 April 2021 in medRxiv
Verified
Preprint
Open access
PDF file
YBYvan Butera
Yvan Butera
EMEnatha Mukantwari
Enatha Mukantwari
MAMaria Artesi
Maria Artesi
JUJeanne D’arc Umuringa
Jeanne D’arc Umuringa
ÁOÁine Niamh O’toole
Áine Niamh O’toole
NRNadine Rujeni
Nadine Rujeni
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for coronavirus disease 19 (COVID-19), is a single-stranded positive-sense ribonucleic acid (RNA) virus that typically undergoes one to two single nucleotide mutations per month. COVID-19 continues to spread globally, with case fatality and test positivity rates often linked to locally circulating strains of SARS-CoV-2. Furthermore, mutations in this virus, in particular those occurring in the spike protein (involved in the virus binding to the host epithelial cells) have potential implications in current vaccination efforts. In Rwanda, more than twenty thousand cases have been confirmed as of March 14 th 2021, with a case fatality rate of 1.4% and test positivity rate of 2.3% while the recovery rate is at 91.9%. Rwanda started its genomic surveillance efforts, taking advantage of pre-existing research projects and partnerships, to ensure early detection of SARS-CoV-2 variants and to potentially contain the spread of variants of concern (VOC). As a result of this initiative, we here present 203 SARS-CoV-2 whole genome sequences analyzed from strains circulating in the country from May 2020 to February 2021. In particular, we report a shift in variant distribution towards the newly emerging sub-lineage A.23.1 that is currently dominating. Furthermore, we report the detection of the first Rwandan cases of the VOCs, B.1.1.7 and B.1.351, among incoming travelers tested at Kigali International Airport. We also discuss the potential impact of COVID-19 control measures established in the country to control the spread of the virus. To assess the importance of viral introductions from neighboring countries and local transmission, we exploit available individual travel history metadata to inform spatio-temporal phylogeographic inference, enabling us to take into account infections from unsampled locations during the time frame of interest. We uncover an important role of neighboring countries in seeding introductions into Rwanda, including those from which no genomic sequences are currently available or that no longer report positive cases. Our results point to the importance of systematically screening all incoming travelers, regardless of the origin of their travels, as well as regional collaborations for durable response to COVID-19.

16 June 2021 in Nature
Verified
Journal Article
Closed access
PDF file
LMLeon Mutesa
Leon Mutesa
PNPacifique Ndishimye
Pacifique Ndishimye
YBYvan Butera
Yvan Butera
Jacob SouopguiJacob Souopgui
Jacob Souopgui
AUAnnette Uwineza
Annette Uwineza
WNWilfred Ndifon
Wilfred Ndifon

5 November 2024 in medRxiv
Verified
Preprint
Open access
PDF file
YBYvan Butera
Yvan Butera
LMLeon Mutesa
Leon Mutesa
EPEdyth Parker
Edyth Parker
RMRaissa Muvunyi
Raissa Muvunyi
EUEsperance Umumararungu
Esperance Umumararungu
Claude Mambo MuvunyiClaude Mambo Muvunyi
Claude Mambo Muvunyi
The ongoing outbreak of Marburg virus disease (MVD) in Rwanda marks the third largest historically, though it has exhibited the lowest fatality rate. Genomic analysis has identified a lineage with limited internal diversity most closely related to a genome sequence from a sporadic case sampled in 2014 in Uganda, though the lineages have diverged from a common ancestor that was circulating for decades in the animal reservoir. Notably, the data also provide evidence that the outbreak resulted from a single zoonotic transmission event with limited human-to-human transmission, rather than multiple independent zoonotic transmission events. The Rwandan MVD outbreak prompted a thorough investigation that included contact tracing, clinical assessment, travel history, sequencing, and serology testing, to trace the virus’s origin. Results of investigations linked the index case to a mining cave inhabited by Rousettus aegyptiacus (the Egyptian fruit bat), where three individuals tested seropositive for IgG and IgM, further supporting the zoonotic origin of the outbreak through human-animal interactions.